Gimbel, MD, J.S., Rauck, MD, R.L., Bass, PharmD, A., Wilson, PharmD, J., Pixton, MS, G., Malhotra, PhD, B., Wilson PhD, G. and Wolfram, MD, G. 2019. Effects of naltrexone exposure observed in two phase three studies with ALO-02, an extended-release oxycodone surrounding sequestered naltrexone. Journal of Opioid Management. 15, 5 (Sep. 2019), 417–427. DOI:https://doi.org/10.5055/jom.2019.0530.